Press release
Oxycodone Drugs Market Report 2024: Size, Share, Growth, Trends, Forecast 2033
Oxycodone Drugs Market
As per the report, the oxycodone drugs market size has grown strongly in recent years. It will grow from $5.25 billion in 2023 to $5.62 billion in 2024 at a compound annual growth rate (CAGR) of 7.0%. The oxycodone drugs market size is expected to see strong growth in the next few years. It will grow to $7.41 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=15886&type=smp
Orthopedic Disorder Surge Fuels Oxycodone Market Growth
The high burden of orthopedic disorders is expected to propel the growth of the oxycodone drug market going forward. Orthopedic disorders refer to a range of musculoskeletal conditions, including bones, joints, ligaments, tendons, and muscles, leading to pain, impaired mobility, and functional limitations. The rising incidence of orthopedic disorders is due to aging populations, sedentary lifestyles, obesity, sports injuries, and occupational hazards. Oxycodone drugs are utilized in orthopedic disorders to alleviate acute and chronic pain resulting from conditions such as fractures, joint injuries, or post-surgical discomfort, providing effective relief by acting on the central nervous system's pain receptors. For instance, in October 2023, according to the Institute for Health Metrics and Evaluation, a US-based research institute, the projected cases of musculoskeletal disorders (orthopedic disorders) are anticipated to rise by 115% (with a range of 107-124%) from 2020 to 2050, reaching an estimated 1,060 million prevalent cases by 2050. Therefore, the high burden of orthopedic disorders is driving the growth of the oxycodone drug market.
Focus On Developing Immediate-Release Tablets To Combat Drug Abuse In Oxycodone Drug Market
Major companies operating in the oxycodone drug market are focusing their efforts on developing innovative drugs, such as oxycodone immediate-release (IR) tablets, to reduce drug abuse via injection and the intranasal route. Oxycodone immediate-release (IR) tablets are a formulation of the opioid analgesic medication oxycodone that is designed to provide rapid pain relief. For instance, in July 2022, Protega Pharmaceuticals LLC, a US-based pharmaceutical company, launched RoxyBond (oxycodone) immediate-release (IR) tablets in the United States. RoxyBond has been authorized by the U.S. Food and Drug Administration (FDA) as an opioid agonist for the treatment of severe pain, necessitating an opioid analgesic when other options are insufficient. RoxyBond is engineered with advanced technology to deter misuse and abuse, rendering it difficult to tamper with physically or chemically. Studies have demonstrated that RoxyBond exhibits a decreased potential for abuse compared to conventional oxycodone tablets, as evidenced by lower ratings for liking the drug and desire to retake the drug.
The oxycodone drugs market covered in this report is segmented -
1) By Drug Type: Short Acting Oxycodone, Long Acting Oxycodone
2) By Dosage Form: Tablets, Capsules, Injections
3) By Indication: Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Post Operative Pain, Other Indications
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15886&type=discount
Major companies operating in the oxycodone drugs market are Pfizer Inc., Johnson & Johnson Services Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd, Purdue Pharma L.P, Endo International plc, Amneal Pharmaceuticals LLC, Mundipharma Pty Limited, Alkermes plc, Mallinckrodt Pharmaceuticals, Alvogen Group Inc., Collegium Pharmaceutical Inc., Lannett Company Inc., Acorda Therapeutics Inc., Camurus AB, Rhodes Pharmaceuticals L.P., KVK Tech Inc., Teikoku Pharma USA Inc., Manus Aktteva Biopharma LLP, Zyla Life Sciences
Contents of the report:
1. Executive Summary
2. Oxycodone Drugs Market Report Structure
3. Oxycodone Drugs Market Trends And Strategies
4. Oxycodone Drugs Market - Macro Economic Scenario
5. Oxycodone Drugs Market Size And Growth
…..
27. Oxycodone Drugs Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/oxycodone-drugs-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ "
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oxycodone Drugs Market Report 2024: Size, Share, Growth, Trends, Forecast 2033 here
News-ID: 3583716 • Views: …
More Releases from The Business research company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Oxycodone
Orthopedic Disorder Surge Fuels Oxycodone Market Growth Driving Market Accelerat …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Oxycodone Drugs Market Size By 2025?
The market for oxycodone drugs has seen a substantial expansion in recent years. Its market size is set to rise from $5.62 billion in 2024 to $5.98 billion in 2025, marking a compound annual growth rate (CAGR) of 6.4%.…
Oxycodone Drugs Top Companies Data Analysis to 2031
The Oxycodone Drugs Market is expected to register a CAGR of 5.4% from 2025 to 2031. The report is segmented By Product (Short-acting, and Long-acting), Application (Pain Management, and De-addiction), Distribution Channel (Hospital Pharmacies, and Retail Pharmacies). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Download PDF Brochure at: https://www.theinsightpartners.com/sample/TIPRE00040896/?utm_source=OpenPR&utm_medium=10413
The List of Companies
Teva Pharmaceutical…
Orthopedic Disorder Surge Fuels Oxycodone Market Growth: A Significant Driver Pr …
The Oxycodone Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Oxycodone Drugs Market Size and Projected Growth Rate?
The oxycodone drugs market has experienced strong growth over the years. It is forecasted to rise from $5.62 billion in 2024 to $6.04 billion…
Oxycodone Market is Booming Worldwide | Pfizer, Apotex, Mylan
The Latest Released Oxycodone market study has evaluated the future growth potential of Global Oxycodone market and provides information and useful stats on market structure and size. The report is intended to provide market intelligence and strategic insights to help decision-makers take sound investment decisions and identify potential gaps and growth opportunities. Additionally, the report also identifies and analyses changing dynamics, and emerging trends along with essential drivers, challenges, opportunities,…
Orthopedic Disorder Surge Fuels Oxycodone Market Growth Driver: Leading Transfor …
What market dynamics are playing a key role in accelerating the growth of the oxycodone drugs market?
The high prevalence of orthopedic disorders is projected to drive the oxycodone drug market. These disorders, which affect the bones, joints, muscles, and soft tissues, cause significant pain and impair mobility. Oxycodone drugs are commonly used to manage acute and chronic pain related to orthopedic conditions. The Institute for Health Metrics and Evaluation (IHME)…
Key Oxycodone Drugs Market Trend for 2025-2034: Focus On Developing Immediate-Re …
What Is the Future Outlook for the Oxycodone Drugs Market's Size and Growth Rate?
The market for oxycodone drugs has experienced robust growth in the past few years. The size of the market is projected to escalate from $5.62 billion in 2024 to $6.04 billion in 2025, with a compound annual growth rate (CAGR) of 7.4%. The historical period's growth is mainly due to an intensive marketing strategy for OxyContin.…
